Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ventyx Biosciences (VTYX – Research Report), ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other Renaissance Technologies portfolio's top stock picks. The American ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 in a research note issued to investors on Thursday,Benzinga reports.

Guy "Dr Disrespect" Beahm has hit out at Twitch, saying he "should've never been banned in the first place" despite admitting to conduct that "leaned too much in the direction of being ...

Dr. Thomas Noguchi, known as the “coroner to the stars,” oversaw the autopsies of many Hollywood celebrities. (Ben Hethcoat/Coroner to the Stars) ...

Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts. Alnylam Pharmaceuticals, Inc. discovers, develops, ...

25 analysts have shared their evaluations of Vertex Pharmaceuticals (NASDAQ:VRTX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table ...